Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Does Covid-19 Escalate Aging Process? a Possible Concern Publisher



Tayeri K1 ; Asadollahi K2 ; Madani N3 ; Haghjooy Javanmard S4
Authors

Source: Advanced Biomedical Research Published:2022


Abstract

A key challenge after the COVID-19 pandemic will be managing the long-term sequelae for the millions of individuals who recover from the disease. Based on the available evidence, our hypothesis is that the SARS-CoV-2 pandemic and its long-term complications will lead to premature aging (in terms of health) of many people in the world. Obviously, to maintain appropriate public health and prevent poor health-care services, countries should think and plan about the health problems and the long-term consequences of SARS-CoV-2 after controlling the COVID-19 pandemic. © 2022 Advanced Biomedical Research | Published by Wolters Kluwer - Medknow.
Other Related Docs
7. Covid-19 Vaccination Challenges: A Mini-Review, Human Vaccines and Immunotherapeutics (2022)
8. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
10. All Together to Fight Covid-19, American Journal of Tropical Medicine and Hygiene (2020)
11. Challenges, Opportunities, and Future Perspectives, Environmental and Health Management of Novel Coronavirus Disease (COVID-19) (2021)
12. The Covid-19 Pandemic and Noncommunicable Disease Service Delivery: An Overview of Global Experiences, Scientific Journal of Kurdistan University of Medical Sciences (2021)
13. The Role of Health Literacy in the Prevention of Covid-19, Journal of Health Literacy (2021)
14. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
16. Insights Into the Sars-Cov2 Outbreak; the Great Global Challenge: A Mini Review, Journal of Cellular and Molecular Anesthesia (2020)
19. Sars-Cov-2 Infection in Cancer Patients, Susceptibility, Outcome and Care, American Journal of the Medical Sciences (2022)